Biotech Lab 4.0
Vaccine development by design
A revolutionary way to accelerate, control and implement processes in real time by creating intelligent networks of equipment and open data systems that govern each other.
AchilleS Vaccines Biotech Lab 4.0 is a new model of early stage development for new biopharmaceutical products, particularly those containing, or consisting of, recombinant proteins (e.g. vaccines, immuno-therapeutics, ), and a new model of pre-clinical R&D.
Our Technology
AchilleS Vaccines exploits integrated technological platforms to identify, select and develop future approaches to deliver effective products.
They Talk About Us
Latest News
-
Presentato al CdA della Fondazione Biotecnopolo di Siena il Progetto Prometheus. Filiera biotecnologica strategica nazionale permanente
Siena – 20/03/2024. Ieri, 19 marzo 2024, è stato inviato ufficialmente al Consiglio di Amministrazione della Fondazione Biotecnopolo di Siena il progetto Prometheus. Il progetto
-
Penta Teams Up with IAVI and Achilles Vaccines to Develop New Treatments for HIV, Emerging Infections and Neglected Diseases
Padova, Italy, 01/02/2024 – Penta - Child Health Research announced a new collaboration with IAVI and Achilles Vaccines to accelerate the development of treatments for
-
InSilicoTrials and AchilleS Vaccines Join Forces to Create Next-Generation Vaccines and Monoclonal Antibodies against infectious Diseases
InSilicoTrials and AchilleS Vaccines have announced a strategic alliance that aims to unite visions, skills, experiences, the multidisciplinary collaboration network and interested institutions to accelerate